Is Merck ready to face the looming patent cliff? Impact of Inflation Reduction Act (IRA) on Keytruda Inflation Reduction Act (IRA) was passed in 2022
Secukinumab, an IL-17A antagonist, is marketed by Novartis under the brand name Cosentyx®. In 2023, Cosentyx® observed the sales of 5 billion dollars, inclusive of
Pharmaceutical innovation, drug pricing, and patient access to essential medicines must work in a concerted fashion. Factors like: end up spiking the drug prices. Such
Inflation Reduction Act: Patients sigh relief but confusion for biosimilar manufacturers The Inflation Reduction Act of 2022 (IRA) was signed into law in the United
